Pancreatic Cancer Research

Digest Map Explore About

Open data from ClinicalTrials.gov, Europe PMC, NIH RePORTER and OpenAlexFor research and education, not medical adviceAbout this project

The Pancreatic Cancer Research Digest

New trials, papers and changes to existing records, compiled daily from the public registries

Thursday, July 30, 202610 items · 0 changes to existing records

← Previous day Next day →

New trial

Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer

Why it was picked newest record on or before this date

NCT07806110 ↗ Jul 30, 2026

In this edition

New trials: 3
New papers: 7
New grants: 0
Other new records: 0
Status changes: 0
Results posted: 0
Retractions: 0
Other updates: 0

New trial

Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

Why it was picked newest record on or before this date

NCT07707674 ↗ Jul 30, 2026

New paper

Admission Glucose and Presenting Symptoms in Relation to Disease Stage in Newly Diagnosed Pancreatic Ductal Adenocarcinoma.

Why it was picked newest record on or before this date

DOI 10.3390/jcm15155965 ↗ Jul 30, 2026

New trial

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

Why it was picked newest record on or before this date

NCT07620574 ↗ Jul 30, 2026

New paper

Predictive value of 18F-FDG PET/CT delta radiomics model for prognosis after neoadjuvant therapy for locally advanced pancreatic cancer.

Why it was picked newest record on or before this date

DOI 10.3389/fonc.2026.1902166 ↗ Jul 30, 2026

Also today

New paper

Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review.

DOI 10.3389/fonc.2026.1901721 ↗ Jul 30, 2026

New paper

Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study.

DOI 10.3389/fimmu.2026.1841783 ↗ Jul 30, 2026

New paper

18F-fluorodeoxyglucose PET/computed tomography-derived radiomics and 2.5D deep learning for noninvasive prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.

DOI 10.1097/mnm.0000000000002212 ↗ Jul 30, 2026

New paper

HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma

What changed

Change tracking began 4 November 2026, after this day, so only its new records are listed.

Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.

DOI 10.1038/s42003-026-10685-z

·

Jul 30, 2026

New paper

Hypoxia-induced metastatic heterogeneity in pancreatic cancer.

DOI 10.1038/s41467-026-76143-w ↗ Jul 30, 2026